Efficient Vascular and Neural Engraftment of Stem Cell-Derived Islets

Area of Science:

• Regenerative Medicine
• Endocrinology
• Transplantation Biology

Background:

• Human islet transplantation for diabetes is limited by poor graft survival.
• Excessive cell death, inflammation, and poor revascularization contribute to transplant failure.
• Pluripotent stem cell-derived islets (SC-islets) offer a potential alternative, but their engraftment is poorly understood.

Purpose of the Study:

• To investigate the engraftment process and vascularization of SC-islets compared to human islets.
• To assess cell apoptosis, vascular density, oxygenation, and reinnervation at 3 months posttransplantation.
• To evaluate amyloid formation in both SC-islet and human islet grafts.

Main Methods:

• Experimental transplantation of SC-islets and human islets.
• Assessment of cell apoptosis rates posttransplantation.
• Analysis of vascular density, structure, and oxygenation.
• Evaluation of nerve ingrowth and amyloid deposition.

Main Results:

• SC-islet grafts exhibited lower apoptosis rates and similar vascular density compared to human islets.
• SC-islet grafts showed significantly higher oxygenation, indicating improved vascular functionality.
• Reinnervation was four- to fivefold higher in SC-islet grafts than in human islet grafts.
• Amyloid formation was observed in both SC-islet and human islet grafts at 1 and 3 months.

Conclusions:

• SC-islets demonstrate superior vascular and neural engraftment compared to human islets.
• Both SC-islets and human islets are prone to amyloid formation, a potential long-term concern.
• SC-islets represent a promising but not yet perfect source for β-cell replacement therapy.